glp-1 drugs covered by medicare CMS Issues Coverage Guidance on Anti-Obesity Some Medicare patients will be

Athletes often report fewer illnesses and faster bounce-back during high-intensity periods

Understanding Tirzepatide Gut Effects Tirzepatide, a dual-agonist for both GLP-1 and GIP (Glucose-dependent Insulinotropic Polypeptide) receptors, offers enhanced efficacy, but its mechanisms still rely heavily on slowing digestion

HC El Greco: Jos Enrique Mario Surez, Jos Luis Quintana Gmez, Jos Antonio Gonzlez-Posada Delgado, Enrique Revilla Pascual, Esperanza Duralde Rodrguez, Milagros Beamud Lagos

Cardone G., Moyer A

Epigenetic regulation of macrophage polarization in wound healing

Further studies have found that P53 can inhibit system Xc- uptake of cystine by downregulating the expression of SLC7A11, thereby affecting the activity of GPX4 and resulting in the reduction of antioxidant capacity, ROS accumulation, and ferroptosis 11